Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can family care boost preterm baby outcomes? new study investigates

NCT ID NCT07364903

Knowledge-focused Sponsor: Laerdal Foundation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether training and involving families in the care of preterm and low-birth-weight babies in hospital units can improve outcomes like shorter hospital stays and better weight gain. Over 1,000 newborns in Ethiopia will take part, with some hospitals using family-integrated care and others standard care. The goal is to see if this low-cost approach helps babies in resource-limited settings.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Family Integrated Newborn Care (behavioral intervention: training, mentoring, and integrating families into care)
What this could lead to
If successful, this could show that family involvement in newborn care units improves survival and weight gain for preterm babies in low-resource settings.
What could go wrong
This is a quasi-experimental study, not a randomized trial, so results may be less reliable. It is also limited to one region in Ethiopia, so findings may not apply elsewhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,020 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All neonates aged 0-28 days admitted to level-2 NCUs in the neonatal care unit, including Kangaroo Mother care ward or mothers' side ward, with conditions that require hospital stay at 48 hours; and * accompanied by at least one parent (preferably a mother) dedicated to spending up to 8 hours per day with the infant Exclusion Criteria: * Neonates with major congenital anomalies * Infants with no family member to accompany the infant, or who do not consent to spend up to 8 hours per day in the NCU * Families with confirmed physical and/or mental problems limiting their capability to communicate and to engage, or those who leave against medical advice

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Family integrated newborn care are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Empowerment

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Family integrated newborn care Family involvement/empowerment Family-centered care Intensive care units, neonatal

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Mekelle General Hospital, Wukro General Hospital and Adigrat General Hospital

    RECRUITING

    Mek'ele, Tigray, 1871, Ethiopia

  • Mekelle General Hospital, Wukro General Hospital and Adigrat General Hospital

    NOT_YET_RECRUITING

    Mek'ele, Tigray, 1871, Ethiopia

More trials for these conditions

Other studies related to the condition(s) this trial covers.